Revolution Medicines earnings were -$1.8B for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest RVMD earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$644.4M, up 42% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, RVMD reported annual earnings of -$1.1B, with 88.5% growth. The next RVMD earnings date is Nov 4, 2026.
Revolution Medicines Earnings Reports & History FAQ
What were Revolution Medicines's earnings last quarter?
On RVMD's earnings call on Aug 5, 2026, Revolution Medicines (NASDAQ: RVMD) reported Q2 2026 earnings per share (EPS) of -$3.06, up 133.59% year over year. Total RVMD earnings for the quarter were -$644.37 million. In the same quarter last year, Revolution Medicines's earnings per share (EPS) was -$1.31.
The next RVMD earnings call is Nov 4, 2026. Add RVMD to your watchlist to be reminded of Revolution Medicines's next earnings date.
Is Revolution Medicines profitable or losing money?
As of the last Revolution Medicines earnings report, Revolution Medicines is currently losing money. Revolution Medicines's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$1.77 billion, a 117.75% increase year over year.
What was RVMD's earnings growth in the past year?
As of Revolution Medicines's earnings date in Aug 5, 2026, Revolution Medicines's earnings has grown year over year. RVMD earnings in the past year totalled -$1.77 billion.
What are Revolution Medicines's earnings expectations?
The current EPS estimate for Revolution Medicines's earnings report in Nov 4, 2026 is -$2.32.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.